Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 5/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | ESR1 | P03372 | 2/20 | 0.61 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.61 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.61 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | GGT1 | P19440 | 1/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guacetisal SCHEMBL29368893 | 1.00 | KDM4E (0.73) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| SCHEMBL31321657 | 0.89 | ESR1 (0.66) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| SCHEMBL29655351 | 0.87 | CA12 (0.59) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| SCHEMBL236191 | 0.87 | CA12 (0.59) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| SCHEMBL11521148 | 0.86 | KDM4E (0.73) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| SCHEMBL16193386 | 0.84 | PTGS2 (0.57) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| Diplosalsalate SCHEMBL30590970 | 0.84 | KDM4E (1.00) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| SCHEMBL2473332 | 0.84 | KDM4E (1.00) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| SCHEMBL20323265 | 0.84 | KMT2A (0.68) | KDM4EHSD17B10LMNACYP1A2CYP2C9 | |
| Diplosalsalate SCHEMBL25398 | 0.84 | KDM4E (1.00) | KDM4EHSD17B10LMNACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| US-11872307-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2024-01-16 | — | — | US | claimed |
| EP-3682872-B1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-01-03 | — | — | EP | claimed |
| WO-2023205619-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-10-26 | — | — | WO | claimed |
| US-20220211616-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2022-07-07 | — | — | US | claimed |
| US-20210046009-A1 | PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS | Grünenthal GmbH (DE) | 2021-02-18 | — | — | US | claimed |
| CN-103102271-A | Industrialized preparation method of guacetisal and medical application of dry suspension | DALIAN MINGSEN PHARMACEUTICAL CO LTD | 2013-05-15 | — | — | CN | claimed |
| WO-2013020527-A1 | UTILIZATION OF ALAPTIDE AS TRANSDERMAL PENETRATION MODIFIER IN PHARMACEUTICAL COMPOSITIONS FOR HUMAN AND VETERINARY APPLICATIONS CONTAINING ANTI-INFLAMMATORY DRUGS AND/OR ANTIMICROBIAL CHEMOTHERAPEUTICS | UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES BRNO FACULTY OF PHARMACY (CZ) | 2013-02-14 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-100484515-C | Guacetisal dry-mixing suspending agents and method of preparing the same | SHANDONG LUOXIN PHARMACY STOCK (CN) | 2009-05-06 | — | — | CN | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| CN-101254172-A | Guacetisal dry-mixing suspending agents and method of preparing the same | SHANDONG LUOXIN PHARMACEUTICAL (CN) | 2008-09-03 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| CN-1593429-A | Novel oral guacetisal solid preparation and its preparing method | LI JIE (CN) | 2005-03-16 | — | — | CN | claimed |